Viridian Therapeutics, Inc. (VRDN)
$18.66+1.74%Close
SELLCRISIS · day 12
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.7B
- Beta
- 0.96
- P/E (TTM)
- -5.16
- Short % float
- 24.35%
- Days to cover
- 8.9
- SI change
- -7.7%
- 1W
- -3.81%
- 1M
- -16.29%
- vs SPY 1W
- -4.97%
- vs SPY 1M
- -19.28%
Industry peers
FMP comparable companies · ranked by market cap
- IBRXBUYImmunityBio, Inc.$10.9BRECOVERYQ 8$10.38+6.05%
- COGTSELLCogent Biosciences, Inc.$5.3BRECOVERYQ 13$30.87+3.06%
- EWTXSELLEdgewise Therapeutics, Inc.$4.3BBEARQ 16$40.30-0.43%
- RCUSSELLArcus Biosciences, Inc.$3.1BRECOVERYQ 17$24.74+2.43%
- CLDXSELLCelldex Therapeutics, Inc.$2.2BCRISISQ 5$32.59+2.01%
- VERASELLVera Therapeutics, Inc.$2.1BCRISISQ 21$29.83+0.50%
- GLPGGalapagos N.V.$1.8B$27.98
- GPCRSELLStructure Therapeutics Inc.$1.6BCRISISQ 14$27.59-0.51%
- OCULSELLOcular Therapeutix, Inc.$1.6BCRISISQ 3$7.25+0.40%
- QURESELLuniQure N.V.$1.6BCRISISQ 17$22.80+0.22%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
